Immix Biopharma, Inc. (IMMX) Financials

IMMX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 22.5 million 2.8 million
2023-06-30 15.6 million 2.4 million
2023-03-31 13.2 million 1.5 million
2022-12-31 14.9 million 1.7 million

IMMX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -3.1 million 737325
2023-06-30 -3.5 million 447656
2023-03-31 -2.1 million 329919
2022-12-31 -3.9 million 230094

IMMX Net Income

No data available :(

IMMX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 19.6 million - -
2023-06-30 12.7 million - -
2023-03-31 11.5 million - -
2022-12-31 13.4 million - -

IMMX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 18.6 million
2023-06-30 15.0 million
2023-03-31 13.9 million
2022-12-31 13.9 million

IMMX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 38912 2.1 million 2.4 million -
2023-06-30 - 2.2 million 1.5 million -
2023-03-31 - 1.3 million 1.2 million -
2022-12-31 - 2.3 million 1.5 million -

IMMX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 1381
2023-06-30 - 506
2023-03-31 - 505
2022-12-31 -89.5 million 566

IMMX

Price: $2.13

52 week price:
1.40
7.75

Earnings Per Share: -0.89 USD

P/E Ratio: -3.08

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 12035

Market Capitalization: 72.9 million

Links: